These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17434731)

  • 1. Naphthyl piperazines with dual activity as 5-HT1D antagonists and 5-HT reuptake inhibitors.
    Bueno AB; Gilmore J; Boot J; Broadmore R; Cooper J; Findlay J; Hayhurst L; Marcos A; Montero C; Mitchell S; Timms G; Tomlinson R; Wallace L; Walton L
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3344-8. PubMed ID: 17434731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors.
    Bromidge SM; Bertani B; Borriello M; Faedo S; Gordon LJ; Granci E; Hill M; Marshall HR; Stasi LP; Zucchelli V; Merlo G; Vesentini A; Watson JM; Zonzini L
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5653-6. PubMed ID: 18799312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
    Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
    J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors.
    Lovell PJ; Blaney FE; Goodacre CJ; Scott CM; Smith PW; Starr KR; Thewlis KM; Vong AK; Ward SE; Watson JM
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1033-6. PubMed ID: 17129726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.
    Zhou D; Stack GP; Lo J; Failli AA; Evrard DA; Harrison BL; Hatzenbuhler NT; Tran M; Croce S; Yi S; Golembieski J; Hornby GA; Lai M; Lin Q; Schechter LE; Smith DL; Shilling AD; Huselton C; Mitchell P; Beyer CE; Andree TH
    J Med Chem; 2009 Aug; 52(15):4955-9. PubMed ID: 19719241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis.
    Timms GH; Boot JR; Broadmore RJ; Carney SL; Cooper J; Findlay JD; Gilmore J; Mitchell S; Moore NA; Pullar I; Sanger GJ; Tomlinson R; Tree BB; Wedley S
    Bioorg Med Chem Lett; 2004 May; 14(10):2469-72. PubMed ID: 15109634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
    Rollema H; Clarke T; Sprouse JS; Schulz DW
    J Neurochem; 1996 Nov; 67(5):2204-7. PubMed ID: 8863532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H; Wang W; Jiang Z; Shang J; Zhang L
    Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat.
    Muraki I; Inoue T; Koyama T
    Eur J Pharmacol; 2008 May; 586(1-3):171-8. PubMed ID: 18423441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
    Seo HJ; Park EJ; Kim MJ; Kang SY; Lee SH; Kim HJ; Lee KN; Jung ME; Lee M; Kim MS; Son EJ; Park WK; Kim J; Lee J
    J Med Chem; 2011 Sep; 54(18):6305-18. PubMed ID: 21823597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives.
    Torrado A; Lamas C; Agejas J; Jiménez A; Diaz N; Gilmore J; Boot J; Findlay J; Hayhurst L; Wallace L; Broadmore R; Tomlinson R
    Bioorg Med Chem; 2004 Oct; 12(20):5277-95. PubMed ID: 15388156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
    Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
    Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB
    J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.